v

A MESSAGE TO THE WORLD FROM THE DIRECTOR-GENERAL,
WORLD HEALTH ORGANIZATION, 2000

     Since the discovery, antibiotics have completely transformed humanity’s approach to infectious disease.  Today, the use of antibiotics combined with improvements in sanitation, housing, and nutrition alongside the advent of widespread vaccination programs, have let to a dramatic drop in once common infectious diseases that formerly laid low entire populations.  Scourges that once struck terror into the hearts of millions—plague, whooping cough, polio, and scarlet fever—have been, or are on the verge of being controlled.  Now, at the dawn of a new millennium, humanity is faced with another crisis.  Formerly curable diseases such as gonorrhea and typhoid are rapidly becoming difficult to treat, while old killers such as tuberculosis and malaria are now arrayed in the increasingly impenetrable amount of antimicrobial resistance.

     This phenomenon is potentially containable.  It is a deepening and complex problem accelerated by the overuse of antibiotics in developing nations and the paradoxical under-use of quality antimicrobials in developing nations owing to poverty and a resultant dearth of effective health care.

     Last year’s infectious diseases report, “Removing Obstacles to Health Development,” demonstrated that communicable diseases remain a significant cause of disability, are responsible for continued high morality and primarily afflict the world’s most vulnerable populations.

     This year’s report focuses on the issue of drug resistance and how this disturbing development is closing the windows of opportunity to treat infectious diseases. By developing a global strategy to contain resistance and building alliances involving al health care provider—countries, government, international organizations, non-governmental organizations and both the private and public hearth care sector—we have an opportunity to launch a massive effort against infectious diseases that perpetuate poverty.  Used wisely and widely, the drugs we have today can be made available to the world’s poorest to prevent health care catastrophes of tomorrow.

This is our challenge and must be our goal.

Dr. Gro Halem Brundland
Director-General, WHO